SE0303280D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0303280D0
SE0303280D0 SE0303280A SE0303280A SE0303280D0 SE 0303280 D0 SE0303280 D0 SE 0303280D0 SE 0303280 A SE0303280 A SE 0303280A SE 0303280 A SE0303280 A SE 0303280A SE 0303280 D0 SE0303280 D0 SE 0303280D0
Authority
SE
Sweden
Prior art keywords
sup
novel compounds
therapy
processes
formula
Prior art date
Application number
SE0303280A
Other languages
English (en)
Inventor
Nafizal Hossain
Svetlana Ivanova
Marguerite Mensonides-Harsema
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303280A priority Critical patent/SE0303280D0/sv
Publication of SE0303280D0 publication Critical patent/SE0303280D0/sv
Priority to CNA2004800368111A priority patent/CN1890248A/zh
Priority to US10/581,171 priority patent/US20070123543A1/en
Priority to JP2006542530A priority patent/JP2007513151A/ja
Priority to PCT/SE2004/001771 priority patent/WO2005054249A1/en
Priority to EP04800422A priority patent/EP1699803A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0303280A 2003-12-05 2003-12-05 Novel compounds SE0303280D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0303280A SE0303280D0 (sv) 2003-12-05 2003-12-05 Novel compounds
CNA2004800368111A CN1890248A (zh) 2003-12-05 2004-11-30 新化合物
US10/581,171 US20070123543A1 (en) 2003-12-05 2004-11-30 Novel compounds
JP2006542530A JP2007513151A (ja) 2003-12-05 2004-11-30 新規化合物
PCT/SE2004/001771 WO2005054249A1 (en) 2003-12-05 2004-11-30 Novel compounds
EP04800422A EP1699803A1 (en) 2003-12-05 2004-11-30 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303280A SE0303280D0 (sv) 2003-12-05 2003-12-05 Novel compounds

Publications (1)

Publication Number Publication Date
SE0303280D0 true SE0303280D0 (sv) 2003-12-05

Family

ID=29997662

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303280A SE0303280D0 (sv) 2003-12-05 2003-12-05 Novel compounds

Country Status (6)

Country Link
US (1) US20070123543A1 (sv)
EP (1) EP1699803A1 (sv)
JP (1) JP2007513151A (sv)
CN (1) CN1890248A (sv)
SE (1) SE0303280D0 (sv)
WO (1) WO2005054249A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202133D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
EP2069355A4 (en) * 2006-07-19 2010-03-24 Astrazeneca Ab NOVEL TRICYCLIC SPIROPIPERIDINE COMPOUNDS, THEIR SYNTHESIS AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
WO2008103126A1 (en) * 2007-02-23 2008-08-28 Astrazeneca Ab Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
WO2009011655A1 (en) * 2007-07-17 2009-01-22 Astrazeneca Ab Splropiperidine compounds, a process of their preparation, pharmaceutical compositions containing them, and their use in the treatment of airway diseases, inflammatory diseases, copd or asthma
WO2009011653A1 (en) * 2007-07-17 2009-01-22 Astrazeneca Ab A process for the preparation of intermediates and their us in the synthesis of spiropiperidine compounds
EP2440563A1 (en) * 2009-06-10 2012-04-18 Sunovion Pharmaceuticals Inc. Histamine h3 inverse agonists and antagonists and methods of use thereof
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
CN101919833B (zh) * 2010-07-16 2012-01-11 暨南大学 一种芳香类化合物作为制备Caspase 3抑制剂的用途
EP2565186A1 (en) 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
CN102816116B (zh) * 2012-07-09 2014-03-26 浙江工业大学 一种6-羟基-2（1h）-喹啉酮化合物的合成方法
CN102816115B (zh) * 2012-07-09 2014-03-26 浙江工业大学 一种羟基取代-3,4-二氢-2（1h）-喹啉酮类化合物的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4010201A (en) * 1974-04-12 1977-03-01 The Upjohn Company Organic compounds
US4166120A (en) * 1978-04-14 1979-08-28 American Hoechst Corporation Analgesic and tranquilizing benzoylpropyl-spiro[dihydrobenzofuran]piperidines and pyrrolidines
US4263317A (en) * 1979-09-06 1981-04-21 Hoechst-Roussel Pharmaceuticals, Inc. Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s
AU5803398A (en) * 1996-12-13 1998-07-03 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
JP2001508798A (ja) * 1997-01-21 2001-07-03 メルク エンド カンパニー インコーポレーテッド ケモカインレセプター活性のモジュレーターとしての３，３−二置換ピペリジン類
US6288083B1 (en) * 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CA2375008C (en) * 1999-05-24 2011-01-04 Mitsubishi Pharma Corporation Phenoxypropylamine compounds
WO2001064213A1 (en) * 2000-03-02 2001-09-07 Smithkline Beecham Corporation Compounds and methods
WO2002102387A1 (en) * 2001-06-18 2002-12-27 H. Lundbeck A/S Treatment of neuropathic pain
SE0202133D0 (sv) * 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
US20070021498A1 (en) * 2004-10-14 2007-01-25 Nafizal Hossain Novel tricyclic spiroderivatives as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
EP1699803A1 (en) 2006-09-13
US20070123543A1 (en) 2007-05-31
JP2007513151A (ja) 2007-05-24
WO2005054249A1 (en) 2005-06-16
CN1890248A (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
IS6658A (is) Ný efnasambönd
SE0302139D0 (sv) Novel compounds
IS6520A (is) Ný efnasambönd
SE0300480D0 (sv) Novel compounds
SE0302811D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
SE0202133D0 (sv) Novel compounds
SE0200920D0 (sv) Novel compounds
SE0104140D0 (sv) Novel Compounds
ATE433447T1 (de) Pyrimiidinverbindungen
SE0300119D0 (sv) Novel compounds
SE0202539D0 (sv) Compounds
SE0103836D0 (sv) Novel compounds
MY128924A (en) Novel compounds
TW200604197A (en) New compounds
SE0302192D0 (sv) Novel compounds
TW200740781A (en) Novel compounds
SE0403171D0 (sv) New compounds
SE0302116D0 (sv) Novel compounds
SE0101038D0 (sv) Novel compounds
SE0402925D0 (sv) Novel Compounds
SE0303280D0 (sv) Novel compounds
SE0102716D0 (sv) Novel compounds
GB0120461D0 (en) Novel compounds
SE0401763D0 (sv) Compounds